Specific Effect of BRAF-Inhibitors on a BRAF-mutant and a Wild-type Cell Line of Malignant Melanoma

被引：0
|
作者：
Steck, M. [1 ]
Grabenbauer, M. [1 ]
Fuenfle, R. [1 ]
Hecht, M. [1 ]
Fietkau, R. [1 ]
Distel, L., V [1 ]
机构：
[1] Friedrich Alexander Univ Erlangen Nurnberg, Strahlenklin, Erlangen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2017年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P22-5-jD
引用
收藏
页码：S169 / S170
页数：2
相关论文
共 50 条
  • [21] Ocular Metastasis of Cutaneous BRAF Wild-Type Melanoma
    Papudesu, Chandana
    Reddy, Shilpa G.
    Potter, Heather D.
    OPHTHALMOLOGY, 2018, 125 (12) : 1966 - 1966
  • [22] Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: from melanoma to tissue-agnostic therapy
    Gouda, M. A.
    Subbiah, V.
    ESMO OPEN, 2023, 8 (02)
  • [23] MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors
    Pinto, Rosamaria
    Strippoli, Sabino
    De Summa, Simona
    Albano, Anna
    Azzariti, Amalia
    Guida, Gabriella
    Popescu, Ondina
    Lorusso, Vito
    Guida, Michele
    Tommasi, Stefania
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (08) : 1027 - 1035
  • [24] Identifying the optimum first-line therapy in BRAF-mutant metastatic melanoma
    Ziogas, Dimitrios C.
    Konstantinou, Frosso
    Bouros, Spyros
    Gogas, Helen
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (01) : 53 - 62
  • [25] Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma
    Johnpulle, Romany A. N.
    Johnson, Douglas B.
    Sosman, Jeffrey A.
    CURRENT ONCOLOGY REPORTS, 2016, 18 (01) : 1 - 8
  • [26] Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells
    Garay, Tamas
    Kenessey, Istvan
    Molnar, Eszter
    Juhasz, Eva
    Reti, Andrea
    Laszlo, Viktoria
    Rozsas, Anita
    Dobos, Judit
    Doeme, Balazs
    Berger, Walter
    Klepetko, Walter
    Tovari, Jozsef
    Timar, Jozsef
    Hegedus, Balazs
    PLOS ONE, 2015, 10 (02):
  • [27] Targeting the MAPK pathway in advanced BRAF wild-type melanoma
    Massa, R. C.
    Kirkwood, J. M.
    ANNALS OF ONCOLOGY, 2019, 30 (04) : 503 - 505
  • [28] Dissecting the impact of MEKi on BRAF wild-type melanoma cells
    Pohlentz, F.
    van der Sluis, T. C.
    Bonifatius, S.
    Shridhar, N.
    Ruotsalainen, J.
    Gaffal, E.
    Tueting, T.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 (03) : E104 - E104
  • [29] Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma
    Romany A. N. Johnpulle
    Douglas B. Johnson
    Jeffrey A. Sosman
    Current Oncology Reports, 2016, 18
  • [30] The BET inhibitor BAY 1238097 shows efficacy in BRAF wild-type and mutant melanoma models
    Haendler, Bernard
    Gelato, Kathy A.
    Schockel, Laura
    Sugawara, Tatsuo
    Lejeune, Pascale
    Ellinger-Ziegelbauer, Heidrun
    Fernandez-Montalvan, Amaury E.
    Holton, Simon
    Siegel, Stephan
    Heroult, Melanie
    Walter, Annette
    Ince, Stuart
    Ocker, Matthias
    CANCER RESEARCH, 2016, 76
12345